Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Sales | 8,521,000 | 6,891,000 | 6,145,200 | 5,112,600 | 5,677,700 |
| Cost of Goods | 4,982,400 | 4,051,300 | 3,641,800 | 2,988,500 | 3,385,700 |
| Gross Profit | 3,538,600 | 2,839,700 | 2,503,400 | 2,124,100 | 2,292,000 |
| Operating Expenses | 2,091,100 | 1,688,700 | 1,479,600 | 1,256,300 | 1,506,100 |
| Operating Income | 1,447,900 | 1,151,300 | 1,024,601 | 868,300 | 786,600 |
| Interest Expense | 308,800 | 153,600 | 77,300 | 63,900 | 74,100 |
| Other Income | 40,200 | -78,400 | 46,999 | 38,200 | 43,700 |
| Pre-tax Income | 1,179,300 | 919,300 | 994,300 | 842,600 | 756,200 |
| Income Tax | 299,300 | 321,800 | 261,100 | 275,300 | 214,200 |
| Net Income Continuous | 812,100 | 577,500 | 716,000 | 552,100 | 525,600 |
| Net Income Discontinuous | 18,000 | 43,600 | 67,800 | 27,100 | N/A |
| Net Income | $830,100 | $621,100 | $783,800 | $579,200 | $525,600 |
| EPS Basic Total Ops | 5.56 | 4.26 | 5.40 | 3.97 | 3.51 |
| EPS Basic Continuous Ops | 5.44 | 3.96 | 4.93 | 3.78 | 3.52 |
| EPS Basic Discontinuous Ops | 0.12 | 0.30 | 0.47 | 0.19 | N/A |
| EPS Diluted Total Ops | 5.42 | 4.13 | 5.23 | 3.86 | 3.41 |
| EPS Diluted Continuous Ops | 5.31 | 3.84 | 4.78 | 3.68 | 3.41 |
| EPS Diluted Discontinuous Ops | 0.11 | 0.29 | 0.45 | 0.18 | N/A |
| EBITDA(a) | $1,702,600 | $1,375,700 | $1,245,601 | $1,060,900 | $965,300 |